Traumen Life Sciences Private Limited, a active private limited company, was established on 15 May 2015 in Virar West, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24233MH2015PTC264497. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a active non-compliant status. Its leadership includes Saurabh Kumar Srivastava (Director), Narendra Bhojesing Jamadar (Director), Chetan Kumar Verma (Director). It holds ₹0.78 M open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Shop No. 26, Giriraj Complex Gokul Township,, Virar West, Maharashtra, 401303.
U24233MH2015PTC264497
264497
15 May 2015
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Traumen Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Saurabh Kumar Srivastava | Director | 15 May 2015 | Current |
| Narendra Bhojesing Jamadar | Director | 15 May 2015 | Current |
| Chetan Kumar Verma | Director | 15 May 2015 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Traumen Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 42.71% increase. The company also saw a substantial improvement in profitability, with a 29.8% increase in profit. The company's net worth Soared by an impressive increase of 19.41%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Traumen Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹780,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Sep 2022 | Idbi Bank Limited | ₹0.78 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Traumen Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Traumen Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Traumen Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Traumen Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
The activity Traumen Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was completed.
Progress on A charge with Idbi Bank Limited amounted to Rs. 0.78 M with Charge ID 100623634 was registered on 09 Sep 2022. was documented.
Progress on Saurabh Kumar Srivastava was appointed as a Director was appointed as a Director on 15 May 2015 & has been associated with this company since 10 years 6 months . was documented.
Progress on Narendra Bhojesing Jamadar was appointed as a Director was appointed as a Director on 15 May 2015 & has been associated with this company since 10 years 6 months . was documented.
Progress on Chetan Kumar Verma was appointed as a Director was appointed as a Director on 15 May 2015 & has been associated with this company since 10 years 6 months . was documented.
The CIN of Traumen Life Sciences Private Limited is U24233MH2015PTC264497.
Traumen Life Sciences Private Limited is headquartered at Shop No. 26, Giriraj Complex Gokul Township,, Virar West, Maharashtra, 401303.
Traumen Life Sciences Private Limited was incorporated on 15 May 2015.
The current directors of Traumen Life Sciences Private Limited are
The primary industry of Traumen Life Sciences Private Limited is Pharma.
Traumen Life Sciences Private Limited is unlisted.
The authorized capital of Traumen Life Sciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Traumen Life Sciences Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX